• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同时测量骨形成和骨吸收标志物以评估绝经后女性骨转换率的可行性:一项EPOLOS研究

Feasibility of simultaneous measurement of bone formation and bone resorption markers to assess bone turnover rate in postmenopausal women: an EPOLOS study.

作者信息

Łukaszkiewicz Jacek, Karczmarewicz Elzbieta, Płudowski Paweł, Jaworski Maciej, Czerwiński Edward, Lewiński Andrzej, Marcinowska-Suchowierska Ewa, Milewicz Andrzej, Spaczyński Marek, Lorenc Roman S

机构信息

Department of Biochemical and Experimental Medicine, The Children's Memorial Health Institute, Warsaw, Poland.

出版信息

Med Sci Monit. 2008 Dec;14(12):PH65-70.

PMID:19043376
Abstract

BACKGROUND

One of the most important risk factors for osteoporotic fractures in postmenopausal women is elevated bone turnover (EBT), occurring in 25-30% of this population. This study's aim was to find a correlation between bone resorption and bone formation markers to assess bone turnover rate and qualify an individual postmenopausal woman as a possible EBT subject.

MATERIAL/METHODS: Three hundred twenty postmenopausal women (> or = one year after the last menstruation, < or = 70 years old) were enrolled at seven clinical sites in this cross-sectional observational study conducted within the EPOLOS. The group was a random sample of the population. The study was performed in a referral center involved in the diagnosis and treatment of osteoporosis. The exclusion criteria included pregnancy, cancer, fracture in the last year, and overweight (> 100 kg). Bone mineral density (BMD) measurements of the lumbar spine, total hip, trochanter, and femoral neck regions were performed. Bone resorption and formation rates were evaluated by serum levels of C-terminal telopeptide of type I collagen (CTX) and osteocalcin (OC), respectively.

RESULTS

Using logistic regression to correlate the concentrations of CTX and OC it was possible not only to distinguish the EBT subgroup, but also to construct a simple nomogram for easy classification of individual patients as possible EBT subjects. EBT patients showed generally decreased BMD values and increased bone formation and resorption rates.

CONCLUSIONS

Evaluation of both CTX and OC levels enables a more proper indication for EBT. The proposed nomogram may assist in evaluating outcome from the two markers of bone turnover.

摘要

背景

绝经后女性骨质疏松性骨折最重要的危险因素之一是骨转换率升高(EBT),该人群中25%-30%会出现这种情况。本研究的目的是找出骨吸收和骨形成标志物之间的相关性,以评估骨转换率,并确定个体绝经后女性是否可能属于EBT人群。

材料/方法:在EPOLOS开展的这项横断面观察性研究中,在7个临床地点招募了320名绝经后女性(末次月经后≥1年,≤70岁)。该组为人群随机样本。研究在一家参与骨质疏松症诊断和治疗的转诊中心进行。排除标准包括妊娠、癌症、去年有骨折史以及超重(>100 kg)。对腰椎、全髋、大转子和股骨颈区域进行骨密度(BMD)测量。分别通过血清I型胶原C末端肽(CTX)和骨钙素(OC)水平评估骨吸收和形成率。

结果

使用逻辑回归分析CTX和OC的浓度,不仅可以区分EBT亚组,还可以构建一个简单的列线图,以便轻松将个体患者分类为可能的EBT人群。EBT患者的BMD值通常较低,骨形成和骨吸收率较高。

结论

评估CTX和OC水平能够更准确地判断EBT情况。所提出的列线图可能有助于评估这两种骨转换标志物的结果。

相似文献

1
Feasibility of simultaneous measurement of bone formation and bone resorption markers to assess bone turnover rate in postmenopausal women: an EPOLOS study.同时测量骨形成和骨吸收标志物以评估绝经后女性骨转换率的可行性:一项EPOLOS研究
Med Sci Monit. 2008 Dec;14(12):PH65-70.
2
Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study.绝经后女性骨转换标志物的长期变异性及其临床应用意义:OFELY研究
J Bone Miner Res. 2003 Oct;18(10):1789-94. doi: 10.1359/jbmr.2003.18.10.1789.
3
Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.骨吸收标志物可预测老年女性髋部骨折:EPIDOS前瞻性研究
J Bone Miner Res. 1996 Oct;11(10):1531-8. doi: 10.1002/jbmr.5650111021.
4
Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.绝经后骨质疏松症患者骨转换标志物与骨密度之间血清脯氨酰肽酶活性的相关性
Arch Gynecol Obstet. 2006 Jun;274(3):133-7. doi: 10.1007/s00404-006-0148-9. Epub 2006 Mar 11.
5
Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.绝经后女性的体重指数(BMI)以及骨形成与骨吸收参数
Maturitas. 2004 Mar 15;47(3):185-93. doi: 10.1016/S0378-5122(03)00282-2.
6
Biochemical markers as predictors of rates of bone loss after menopause.生化标志物作为绝经后骨质流失率的预测指标。
J Bone Miner Res. 2000 Jul;15(7):1398-404. doi: 10.1359/jbmr.2000.15.7.1398.
7
Relationship between bone turnover and bone density at the proximal femur in stroke patients.中风患者股骨近端骨转换与骨密度的关系。
J Stroke Cerebrovasc Dis. 2009 Mar-Apr;18(2):139-43. doi: 10.1016/j.jstrokecerebrovasdis.2008.09.013.
8
Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.I型胶原C末端肽、骨特异性碱性磷酸酶和骨钙素在绝经后女性骨状态评估中的作用
J Obstet Gynaecol Res. 2009 Feb;35(1):152-9. doi: 10.1111/j.1447-0756.2008.00868.x.
9
Bone turnover markers in Spanish postmenopausal women: the Camargo cohort study.西班牙绝经后女性的骨转换标志物:卡马戈队列研究
Clin Chim Acta. 2009 Nov;409(1-2):70-4. doi: 10.1016/j.cca.2009.08.020. Epub 2009 Sep 6.
10
Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements.使用生化标志物和骨密度测量评估绝经后2型糖尿病患者的骨转换情况。
Gynecol Endocrinol. 2003 Feb;17(1):19-29.

引用本文的文献

1
Evaluation of the validity of treatment decisions based on surrogate country models before introduction of the Polish FRAX and recommendations in comparison to current practice.在引入波兰FRAX之前,基于替代国家模型评估治疗决策的有效性,并与当前实践进行比较并提出建议。
Arch Med Sci. 2018 Mar;14(2):345-352. doi: 10.5114/aoms.2016.60823. Epub 2016 Jun 23.
2
Bone Turnover Markers and Osteoprotegerin in Uncomplicated Pregnancy.正常妊娠中的骨转换标志物与骨保护素
EJIFCC. 2009 Jan 20;19(4):193-202. eCollection 2009 Jan.
3
Serum levels of the bone turnover markers dickkopf-1, sclerostin, osteoprotegerin, osteopontin, osteocalcin and 25-hydroxyvitamin D in Swedish geriatric patients aged 75 years or older with a fresh hip fracture and in healthy controls.
瑞典75岁及以上新发髋部骨折老年患者与健康对照者血清中骨转换标志物Dickkopf-1、硬化蛋白、骨保护素、骨桥蛋白、骨钙素和25-羟基维生素D的水平。
J Endocrinol Invest. 2016 Aug;39(8):855-63. doi: 10.1007/s40618-015-0421-5. Epub 2016 Feb 5.
4
Teriparatide vs. alendronate as a treatment for osteoporosis: changes in biochemical markers of bone turnover, BMD and quality of life.特立帕肽与阿仑膦酸钠治疗骨质疏松症:骨转换生化标志物、骨密度和生活质量的变化。
Med Sci Monit. 2011 Aug;17(8):CR442-448. doi: 10.12659/msm.881905.
5
Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis.生物标志物在治疗骨关节炎药物开发中的应用。
Osteoarthritis Cartilage. 2011 May;19(5):515-42. doi: 10.1016/j.joca.2010.08.019. Epub 2011 Mar 23.
6
The soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women.大豆异黄酮减少骨质流失(SIRBL)研究:一项针对绝经后妇女的 3 年随机对照试验。
Am J Clin Nutr. 2010 Jan;91(1):218-30. doi: 10.3945/ajcn.2009.28306. Epub 2009 Nov 11.
7
Estimation of serum osteocalcin and telopeptide-C in postmenopausal osteoporotic females.绝经后骨质疏松女性血清骨钙素和肽 C 的估算。
Osteoporos Int. 2010 May;21(5):751-5. doi: 10.1007/s00198-009-1001-3. Epub 2009 Jul 14.